Mgr. Marek Večeřa
Research specialist - PhD student, Ondřej Slabý Research Group
office: bldg. E35/225
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 6295 |
---|---|
e‑mail: | marek.vecera@ceitec.muni.cz |
social and academic networks: |
---|
Total number of publications: 48
2025
-
Detection of early relapse in multiple myeloma patients
Cell Division, year: 2025, volume: 20, edition: 1, DOI
-
MicroRNA Analysis in Meningiomas with Different Degrees of Tissue Stiffness: A Potential Tool for Effective Preoperative Planning
Neurosurgery, year: 2025, DOI
-
MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia
Hematological Oncology, year: 2025, DOI
2024
-
Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients
Scientific Reports, year: 2024, volume: 14, edition: 1, DOI
2023
-
Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin
CANCER GENOMICS & PROTEOMICS, year: 2023, volume: 20, edition: 1, DOI
-
Spinal Metastasis in a Patient with Supratentorial Glioblastoma with Primitive Neuronal Component: A Case Report with Clinical and Molecular Evaluation
Diagnostics, year: 2023, volume: 13, edition: 2, DOI
-
Tumor tissue and cerebrospinal fluid microRNA profiles enable the classification of brain metastasis accordingly to their origin
Year: 2023, type: Conference abstract
2022
-
COMBINED LOCAL TREATMENT OF BRAIN METASTASES: SURGERY AND POSTOPERATIVE STEREOTACTIC RADIOTHERAPY
Year: 2022, type: Conference abstract
-
HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation
CANCER GENOMICS & PROTEOMICS, year: 2022, volume: 19, edition: 2, DOI
-
Sekvenování mikroRNA v mozkových metastázách jako nový diagnostický nástroj
Klinická onkologie, year: 2022, volume: 35, edition: Supplementum 1, DOI